AKRO - Balance Sheet - Akero Therapeutics, Inc.

Current Liabilities	39.8 M
Accounts Payable	9.03 M
Short-Term Debt	631 K
Other Current Liabilities	30.1 M
Non-Current Liabilities	36 M
Long-Term Debt	35.8 M
Other Non-Current Liabilities	194 K

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	340.2	234.2	249.8	150.5	187.2	136.4	76.0	0.6
Short Term Investments	402.8	315.8	101.7	37.8	81.1	71.6	0	0
Receivables	0	0	0	0	0	0	0	0
Inventory	0	0	0	0	0	0	0	0
Other Current Assets	27.3	10.0	7.4	10.6	5.9	3.3	2.3	80 K
Total Current Assets	770.4	560.0	355.2	193.6	271.3	138.0	77.1	0.6
PP&E	0.8	1.0	1.3	1.5	1.8	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0
Long Term Investments	54.8	19.3	0	0	40 K	40 K	20 K	20 K
Other Long Term Assets	0	0	0.1	0.4	0.2	29 K	0	0
Other Assets	0	0	0	0	0	0	0	0
Total Assets	825.9	580.3	356.6	195.5	273.3	138.1	77.2	0.7
LIABILITIES
Accounts Payable	9.0	7.0	8.0	6.7	3.4	0.9	1.4	60 K
Short Term Debt	0.6	0.5	0.3	0.2	0.3	85 K	0	0
Other Current Liabilities	30.1	11.6	10.8	18.2	9.4	8.3	1.0	0.2
Total Current Liabilities	39.8	19.1	19.1	25.1	13.1	9.4	2.3	0.2
Long Term Debt	35.8	25.8	10.6	2.6	3.0	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0
Other Liabilities	0.2	54 K	0.3	(1.3)	(1.5)	23 K	124.7	5.0
Total Liabilities	75.8	45.0	30.0	26.4	14.6	9.4	127.1	5.2
EQUITY
Common Stock	7 K	6 K	5 K	4 K	4 K	3 K	0	0
Retained Earnings	(826.2)	(574.1)	(422.3)	(310.3)	(209.5)	(130.3)	(86.6)	(4.6)
Other Accumulative Comprehensive Income/Loss	0.9	0.3	37 K	27 K	3 K	6 K	0	0
Total Equity	750.1	535.3	326.6	169.1	258.7	128.7	(49.9)	(4.6)
Total Liabilities and Equity	825.9	580.3	356.6	195.5	273.3	138.1	77.2	0.7
SHARES OUTSTANDING
Common Shares Outstanding	67.1	52.6	39.0	34.8	31.5	15.1	21.2	28.6

Free